S100A1 and myocardial infarction: Given concomitant release of various alarmins from damaged cardiomyocytes (Zhang et al, 2012), it is tempting to speculate that S100A1 liberation might mitigate actions of pro-fibrotic alarmins, thereby preventing exaggerated post-MI fibrosis.